Advertisement

Ronald Walters, MD, and Ruth O’Regan, MD, Elected to NCCN Board of Directors


Advertisement
Get Permission

Ronald Walters, MD

Ronald Walters, MD

Ruth O’Regan, MD

Ruth O’Regan, MD

The National Comprehensive Cancer Network® (NCCN®) recently announced the election of Ronald Walters, MD, to the role of Chair of the Board of Directors and Ruth O’Regan, MD, was named Vice Chair.

Dr. Walters is Associate Head for the Institute for Cancer Care Innovation and a breast cancer oncologist at The University of Texas MD Anderson Cancer Center. He’s been a member of the NCCN Board of Directors since 2012 and has served on the NCCN Executive Committee since 2016. He has emphasized a focus on health-care reform and systemic changes to improve quality and address rising costs of cancer care.

Dr. O’Regan is the Division Head of Hematology and Oncology and Associate Director for Clinical Research at the University of Wisconsin Carbone Cancer Center. She is an internationally recognized breast cancer physician whose research is focused on identifying new therapies for triple-negative breast cancer.

Drs. Walters and O’Regan succeed Timothy J. Eberlein, MD, of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, and Jan C. Buckner, MD, of Mayo Clinic Cancer Center, outgoing Chair and Vice Chair, respectively. Board Treasurer Patrick J. O’Brien, MBA, of Fox Chase Cancer Center, and Secretary Lori C. Pickens, MHA, of Yale Cancer Center/Smilow Cancer Hospital, continue as officers of the NCCN Board of Directors. 


Advertisement

Advertisement



;
Advertisement